OHRI MANU (Chief Financial Officer) received a stock award from GT BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/19/2022ACC: 0001493152-22-019872
Officer· Chief Financial Officer
Since Feb 2022
+300K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
400K acquired · 100K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+100K
Price / share
—
Trade value
—
% of position
New position
7/15/2022
0.00→100K
Common Stock
Direct
Shares
−100K
Price / share
—
Trade value
—
% of position
New position
7/15/2022
100K→0.00
Common Stock
Indirect
Shares
+100K
Price / share
—
Trade value
—
% of position
New position
7/15/2022
0.00→100K
Total
Net shares
+100K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/15/2022 | A · Award | +100K | — | — | New position | 0.00 | 100K |
| Common Stock Direct | 7/15/2022 | J · J | −100K | — | — | New position | 100K | 0.00 |
| Common Stock Indirect | 7/15/2022 | J · J | +100K | — | — | New position | 0.00 | 100K |
| Total | +100K | $0.00 | ||||||
Derivative Transactions1
Option to purchase Common Stock
Direct
Converts to
Common Stock
200K shares
Shares
+200K
Strike price
2.48
Held after
200K
Exercisable
—
7/15/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to purchase Common Stock Direct | Common Stock200K shares | 7/15/2022 | A · Award | +200K | 2.48 | — | 200K |